NUMB and lung carcinoma: Interestingly, Numb-PRRL was overexpressed in hepatocellular carcinoma [14], medulloblastoma [10, 26] and invasive urothelial carcinoma of the bladder [27], but exhibited low expression in breast [11] and lung cancers [12].